| PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression H Tang, Y Liang, RA Anders, JM Taube, X Qiu, A Mulgaonkar, X Liu, ... The Journal of Clinical Investigation 128 (2), 2018 | 483 | 2018 |
| Gliomas interact with non-glioma brain cells via extracellular vesicles X Gao, Z Zhang, T Mashimo, B Shen, J Nyagilo, H Wang, Y Wang, Z Liu, ... Cell reports 30 (8), 2489-2500. e5, 2020 | 74 | 2020 |
| Theranostic nanoseeds for efficacious internal radiation therapy of unresectable solid tumors S Moeendarbari, R Tekade, A Mulgaonkar, P Christensen, S Ramezani, ... Scientific reports 6 (1), 20614, 2016 | 72 | 2016 |
| Xenosiderophore utilization promotes Bacteroides thetaiotaomicron resilience during colitis W Zhu, MG Winter, L Spiga, ER Hughes, R Chanin, A Mulgaonkar, ... Cell host & microbe 27 (3), 376-388. e8, 2020 | 67 | 2020 |
| Drug disposition and drug-drug interaction data in 2013 FDA new drug applications: a systematic review J Yu, TK Ritchie, A Mulgaonkar, I Ragueneau-Majlessi Drug Metabolism and Disposition 42 (12), 1991-2001, 2014 | 61 | 2014 |
| PD-L1 detection using 89 Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response J Vento, A Mulgaonkar, L Woolford, K Nham, A Christie, A Bagrodia, ... Journal for ImmunoTherapy of Cancer 7 (144), 2019 | 59 | 2019 |
| Control of cerebral ischemia with magnetic nanoparticles JM Jia, PD Chowdary, X Gao, B Ci, L Wenjun, A Mulgaonkar, EJ Plautz, ... Nature Methods, 2016 | 51 | 2016 |
| Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters A Mulgaonkar, J Venitz, DH Sweet Expert Opinion on Drug Metabolism & Toxicology 8 (5), 553-569, 2012 | 38 | 2012 |
| Human Organic Cation Transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as Disposition Pathways for Fluoroquinolone Antimicrobials A Mulgaonkar, J Venitz, D Gründemann, DH Sweet Antimicrobial agents and chemotherapy 57 (6), 2705-2711, 2013 | 35 | 2013 |
| Organic anion transporter 6 (Slc22a20) specificity and Sertoli cell-specific expression provide new insight on potential endogenous roles GW Schnabolk, B Gupta, A Mulgaonkar, M Kulkarni, DH Sweet Journal of Pharmacology and Experimental Therapeutics 334 (3), 927-935, 2010 | 27 | 2010 |
| Bombesin functionalized 64Cu-copper sulfide nanoparticles for targeted imaging of orthotopic prostate cancer H Cai, F Xie, A Mulgaonkar, L Chen, X Sun, JT Hsieh, F Peng, R Tian, L Li, ... Nanomedicine 13 (14), 1695-1705, 2018 | 24 | 2018 |
| Hollow gold nanoparticles as efficient in vivo radiosensitizing agents for radiation therapy of breast cancer A Mulgaonkar, S Moeendarbari, W Silvers, G Hassan, X Sun, Y Hao, ... Journal of Biomedical Nanotechnology 13 (5), 566-574, 2017 | 23 | 2017 |
| A renal cell carcinoma tumorgraft platform to advance precision medicine R Elias, VT Tcheuyap, AK Kaushik, N Singla, M Gao, OR Torras, ... Cell reports 37 (8), 2021 | 21 | 2021 |
| Radiolabeling strategies and pharmacokinetic studies for metal based nanotheranostics S Ranjbar Bahadori, A Mulgaonkar, R Hart, CY Wu, D Zhang, A Pillai, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 13 (2 …, 2021 | 19 | 2021 |
| Imaging of Actively Proliferating Bacterial Infections by Targeting the Bacterial Metabolic Footprint with d-[5-11C]-Glutamine PJ Renick, A Mulgaonkar, CM Co, CY Wu, N Zhou, A Velazquez, ... ACS infectious diseases 7 (2), 347-361, 2021 | 17 | 2021 |
| ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma A Mulgaonkar, R Elias, L Woolford, B Guan, K Nham, P Kapur, A Christie, ... Clinical Cancer Research 28 (22), 4907-4916, 2022 | 9 | 2022 |
| Gold Nanoparticles in Current Biomedical Applications S Moeendarbari, A Mulgaonkar, AS Hande, W Silvers, C Zhang, Y Liu, ... Reviews in Nanoscience and Nanotechnology 5 (1), 28-78, 2016 | 8 | 2016 |
| Grafting islets to a dissected peritoneal pouch to improve transplant survival and function K Kumano, S Vasu, Y Liu, ST Lo, A Mulgaonkar, J Pennington, ... Transplantation 104 (11), 2307-2316, 2020 | 5 | 2020 |
| Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy A Mulgaonkar, D Udayakumar, Y Yang, S Harris, OK Öz, ... Frontiers in Medicine 10, 1199146, 2023 | 3 | 2023 |
| PET Imaging of Active Invasive Fungal Infections with d-[5-11C]-Glutamine CM Co, A Mulgaonkar, N Zhou, S Harris, OK Oz, L Tang, X Sun ACS infectious diseases 8 (8), 1663-1673, 2022 | 2 | 2022 |
Douglas SweetE. Claiborne Robins Distinguished Professor and Chair, Virginia Commonwealth UniversityVerified email at vcu.edu
